Sanofi allies with OpenAI, Formation Bio for AI use in drug development / Photo: Kirill KUDRYAVTSEV - AFP/File
-
Shock threat by billionaire Bollore's Canal+ group rocks French cinema
-
Kohli, Venkatesh dazzle as Bengaluru qualify for IPL play-offs
-
Probes ongoing into alleged abuse at 84 Paris preschools: prosecutor
-
Di Giannantonio wins Catalan MotoGP Grand Prix, Alex Marquez injured in horror crash
-
Fernandes equals assist record as Man Utd edge Forest thriller
-
Earps to leave PSG, in talks with London City Lionesses
-
Bowlers, Joy put Bangladesh on top in second Pakistan Test
-
Alex Marquez injured in horrific Catalan MotoGP crash
-
'Message for friends and foes': Libyan National Army conducts grand exercises
-
Bayern's Neuer sidelined again with leg issue
-
Adam Driver shuts down question about clashes with Lena Dunham
-
British soprano Felicity Lott dies aged 79
-
Roma near Champions League return with derby triumph, Napoli secure top four
-
Denmark's Antonsen wins badminton Thailand Open title
-
'Toxic' males Trump, Putin, Netanyahu to blame for wars, says star Bardem
-
Iran have 'constructive' meeting with FIFA over World Cup preparations
-
'Peaky Blinders' creator says he has licence to reinvent James Bond
-
Xabi Alonso appointed Chelsea manager on four-year deal
-
Mass Ukraine drone barrage kills 4 in Russia: Moscow
-
Gucci takes over New York's Times Square for fashion show
-
Lyles says 'well worth the journey' after winning 100m in Tokyo
-
Nepali duo break own records on Everest
-
North Korean women footballers land in South ahead of rare match
-
North Korean women footballers arrive in South Korea: AFP
-
Rousey demolishes Carano in MMA comeback fight
-
German 'chemical town' fears impact of industrial decline
-
Qantas flight diverted after man bites flight attendant
-
India scrambles to steady rupee as oil shock bites
-
McGregor to make UFC return with Holloway rematch
-
WHO declares international emergency as Ebola outbreak kills more than 80 in DR Congo
-
Crackdown in Southeast Asia pushes scam networks to Sri Lanka
-
'Geek' hangout to tourist draw: Japan's maid cafes
-
Spacecraft to probe how Earth fends off raging solar winds
-
Bulgaria's 'Bangaranga' wins Eurovision, with Israel second
-
Musk wants SpaceX to go public. Here's how it works
-
Big risks and rewards in upcoming IPOs at SpaceX, OpenAI, Anthropic
-
Pal in last duo could ease nerves for PGA leader Smalley
-
Ronaldo suffers more agony as Al Nassr lose 1-0 in AFC final
-
Venezuela expels Maduro ally Alex Saab to US again
-
Rising star Woad in charge at LPGA Queen City Championship
-
Rodgers returning with Steelers for 22nd season
-
Rahm on PGA: 'It's a battle out there'
-
Dara: dancing to victory at Eurovision
-
Tempo Mails Announces Free Temporary Email Generator with Instant Disposable Email Addresses
-
Penny Stock Enthusiasts, The Momentum Continues: As U.S. Markets Rally to Historic All-Time Highs - Higher Than the Dot-Com Boom Era - ELEKTROS Inc. Celebrates a Strong Friday Closing Surge of 33.33% While Continuing to Aggressively Advance Its Lithium Mining and EV Patent Technology
-
As U.S. Markets Continue Soaring to Historic All-Time Highs Reminiscent of the Dot-Com Boom Era, ELEKTROS Inc. Celebrates a Powerful 33.33% Friday Surge While Advancing Its Vision in Lithium Mining, EV Infrastructure, and Next-Generation Electrification Technologies
-
SMX and the New Age of Parity: When Certified Recycling Becomes Economic Infrastructure
-
As U.S. Markets Continue Surging to Historic All-Time Highs, ELEKTROS Believes This Could Be a Defining Opportunity for Penny Stock Investors Seeking Exposure to the Future of Lithium Mining, EV Infrastructure, and Next-Generation Electrification Technologies
-
Napoleon Solo wins 151st Preakness Stakes
-
Last 10 Eurovision winners
Sanofi allies with OpenAI, Formation Bio for AI use in drug development
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.
AI is playing an ever greater role in developing new medicines, as well as identifying new applications for existing drugs.
It can be used for example to find new molecules more quickly and to improve clinical tests by vetting which patients would be most likely to respond to treatments.
By combining their resources, the three companies "can reimagine drug development in the pharma industry," said Benjamine Liu, chief executive of Formation Bio.
Sanofi has in recent years cooperated on AI with biotechnology companies such as Owkin, Exscientia, Insilico Medicine, Amunix Pharmaceuticals, Atomwise and Aqemia.
In a statement, Sanofi said: "The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle."
"Sanofi will leverage this partnership to provide access to proprietary data to develop AI models as it continues on its path to becoming the first biopharma company powered by AI at scale," it said.
OpenAI "will contribute access to cutting-edge AI capabilities, including the ability to fine-tune models, deep AI expertise and dedicated thought partnership and resources."
P.Santos--AMWN
